Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | HRH1 | P35367 | 2/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.47 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.46 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.45 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.45 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29671568 | 0.81 | CYP2A6 (0.58) | CYP2A6TDP1L3MBTL1HRH1CHRNA7 | |
| SCHEMBL5728469 | 0.81 | HRH1 (0.43) | TDP1L3MBTL1HRH1HRH3CYP1A2 | |
| SCHEMBL11012977 | 0.77 | CYP11B1 (0.66) | CYP2A6TDP1L3MBTL1HRH1TBXAS1 | |
| SCHEMBL724788 | 0.76 | TDP1 (0.80) | CYP2A6TDP1L3MBTL1HRH1CHRNA7 | |
| SCHEMBL29485677 | 0.76 | CYP2A6 (0.76) | CYP2A6TDP1L3MBTL1HRH1CHRNA7 | |
| SCHEMBL2843094 | 0.76 | CYP2A6 (0.76) | CYP2A6TDP1L3MBTL1HRH1CHRNA7 | |
| SCHEMBL29485675 | 0.76 | TDP1 (0.80) | CYP2A6TDP1L3MBTL1HRH1CHRNA7 | |
| SCHEMBL8199794 | 0.75 | TDP1 (0.71) | CYP2A6TDP1L3MBTL1HRH1CHRNA7 | |
| SCHEMBL8200325 | 0.75 | CYP2A6 (0.68) | CYP2A6TDP1L3MBTL1HRH1CHRNA7 | |
| SCHEMBL8658187 | 0.74 | HRH1 (0.81) | CYP2A6TDP1L3MBTL1HRH1CHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1644320-A1 | INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2006-04-12 | — | — | EP | disclosed |
| WO-2005009941-A1 | INDANE DERIVATES AS MUSCARINIC RECEPTOR AGONISTS | ELI LILLY AND COMPANY (US) | 2005-02-03 | — | — | WO | disclosed |